Precision Medicine for Memory
Memory Impairment, Alzheimer's Disease Risk
CommercialActive
Key Facts
Indication
Memory Impairment, Alzheimer's Disease Risk
Phase
Commercial
Status
Active
Company
About MindX Sciences
MindX Sciences, founded in 2019 and based in Cambridge, USA, is pioneering a data-driven, biomarker-based platform for precision mental health. The company's core offering appears to be the MindX One™ blood test, a liquid biopsy designed for the objective assessment of conditions like stress, pain, and memory impairment, with the goal of guiding personalized treatment. Recent achievements include winning the Mayo ASU Healthcare Accelerator competition in 2026 and securing key patent allowances, indicating a focus on commercializing its diagnostic technology and building partnerships.
View full company profile